GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.
暂无分享，去创建一个
A. Feldman | T. Habermann | Dafydd G. Thomas | M. Lim | M. Pittelkow | S. Ansell | T. Witzig | A. Hristov | K. Ristow | R. Wilcox | L. Wellik | Tianjiao Wang | T. Lanigan | S. Ziesmer | N. Bailey | D. Wada | Ye Lu | Avery Polk | R. Briski | Robert Briski